On April 16, 2021, President Joseph Biden of the United States and Prime Minister Yoshihide Suga of Japan held a meeting in Washington DC. This
The Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) and FGFJ have come together to produce an animated video in Japanese introducing the roles and impacts of the Global Fund and it’s partnership over the past 20 years in the fight against the three major infectious diseases globally.
Mark Dybul discusses the Global Fund’s work on controlling the three major infectious diseases at the FGFJ Diet Task Force breakfast meeting. ©FGFJ 2015 This
The Friends of the Global Fund, Japan (FGFJ) and Asahi GLOBE+ are pleased to introduce Dr. Zolelwa Sifumba, a young physician from South Africa, in the second installment of our interview series, “Infectious Diseases Without Borders–Our Story.”
On November 10, 2020, FGFJ held a combined session that represented the third meeting this year of FGFJ Diet Task Force and the first
Erika speaks about the role of transgender people in Global Fund decision-making process at an international conference, Peru, 2019. Behind the news about infectious diseases,
The Friends of the Global Fund, Japan (FGFJ), in collaboration with the Asahi Shimbun, one of Japan’s leading national newspapers, has launched a series of
The Global Fund’s Executive Director Peter Sands joined the first virtual FGFJ Diet Task Force meeting to discuss the current impact of COVID-19 on AIDS,
On May 4, the European Union, France, Germany, Japan, and other partners hosted a Coronavirus Global Response international pledging conference to start the process of
On April 25th, World Malaria Day, the 7th Zero Malaria Award will be presented to Dr. Osamu Kunii, the Head of Strategy Investment and Impact
On March 10, the FGFJ Diet Task Force met with Dr. Noboru Minakawa of the Nagasaki University for Tropical Diseases and Dr. Shigeyuki Kano, director
With a March 27 vote, the Diet approved US$476 million in contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria. This included $72.7 million
